7T MRI Predicts Amelioration of Neurodegeneration in the Brain after AAV Gene Therapy
Open Access
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 17, 258-270
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (F32 NS080488, R01 HD060576)
This publication has 35 references indexed in Scilit:
- Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline ModelMolecular Therapy, 2017
- Astrocytes and lysosomal storage diseasesNeuroscience, 2016
- MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosisAmerican Journal of Medical Genetics Part A, 2015
- AAV-Mediated Gene Delivery in Adult GM1-Gangliosidosis Mice Corrects Lysosomal Storage in CNS and Improves SurvivalPLOS ONE, 2010
- MR Imaging Findings in 2 Cases of Late Infantile GM1 GangliosidosisAmerican Journal of Neuroradiology, 2009
- Brain Proton Magnetic Resonance Spectroscopy and Neuromuscular Pathology in a Patient With GM1 GangliosidosisJournal of Child Neurology, 2007
- Proton MR spectroscopy in three children with Tay-Sachs diseasePediatric Radiology, 2005
- Gene therapy for lysosomal storage diseases: the lessons and promise of animal modelsThe Journal of Gene Medicine, 2004
- Fine needle aspiration cytology of Tay-Sachs disease. A case report.1995
- The Gangliosidoses: Comparative Features and Research ApplicationsVeterinary Pathology, 1979